Fund Advisors of America Inc’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$827K Sell
3,287
-504
-13% -$108K 0.75% 44
2026
Q1
$825K Sell
3,791
-134
-3% -$29.7K 0.84% 39
2025
Q4
$897K Buy
+3,925
New +$894K 0.82% 39

Other funds holding ABBV

Fund Advisors of America Inc's ABBV Position: Q2 2026 in Review

Fund Advisors of America Inc reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $108K and leaving 3,287 shares worth $827K. The position accounts for 0.75% of the portfolio, ranked #44.

Fund Advisors of America Inc first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $897K in Q4 2025. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fund Advisors of America Inc held 3,287 shares of AbbVie worth $827K as of Q2 2026.
  • Fund Advisors of America Inc sold 504 AbbVie shares in Q2 2026, an estimated $108K.
  • AbbVie made up 0.75% of Fund Advisors of America Inc's portfolio in Q2 2026, its #44 holding.
  • Fund Advisors of America Inc first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Fund Advisors of America Inc's AbbVie position peaked at $897K in Q4 2025.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fund Advisors of America Inc's 13F filing for Q2 2026, filed 11 Aug 2026.